Literature DB >> 34325045

Can seasonal influenza vaccine for 2019/2020 has cross reactivity with some of SARS-CoV-2 proteins?

Milad Zandi1, Emad Behboudi2, Saber Soltani3.   

Abstract

Entities:  

Year:  2021        PMID: 34325045      PMCID: PMC8312046          DOI: 10.1016/j.ijid.2021.07.053

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


× No keyword cloud information.
Dear Editor, Since December 2019, when severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged, several studies have examined the similarities and differences between SARS-CoV-2 and influenza viruses. In a recent study by Ilic et al., which was published in International Journal of Infectious Diseases, the authors stated that SARS-CoV-2 has an hemagglutinin-esterase (HE) glycoprotein. This study also suggested that the seasonal influenza vaccine for 2019/2020, which contained three or four strains of influenza A and B viruses, may have had cross reactivity with some SARS-CoV-2 proteins (Ilic et al., 2021); however, the proteins of these two different viruses are not the same. The SARS-CoV-2 and influenza viruses are both enveloped with an encapsulated single-stranded RNA genome. However, their genomes vary in terms of polarity and segmentation. Influenza viruses have 7-8 segmented, negative-sense, single-stranded RNA genomes, while the SARS-CoV-2 genome comprises a non-segmented, positive-sense, single-stranded RNA (Pormohammad et al., 2020). The Orthomyxoviridae family contains three major viruses: influenza types A, B and C. Influenza C carries seven encapsulated segments of negative-sense genomes encoding its structural proteins and non-structural proteins. It can encode a single envelope glycoprotein, named hemagglutinin-esterase-fusion factor (HEF), which is a single multifunction protein and plays a key role in attachment, fusion and receptor destruction. Influenzas A and B comprise eight encapsulated genomic segments and can encode two membrane glycoproteins: haemagglutinin (HA) and neuraminidase (NA). HA plays a key role in attachment and fusion, and NA plays an important role in receptor destruction and release of virions (Wang and Veit, 2016). SARS-CoV-2 is a member of the Coronaviridae family; this viral family has four genera: alpha-coronavirus, beta-coronavirus, gamma-coronavirus and delta-coronavirus (Hosseini et al., 2021). The beta-coronavirus genus comprises five sub-genera: Embecovirus or lineage A (OC43-CoV, HKU1-CoV); Sarbecovirus or lineage B (SARS-CoV-2, SARS-CoV); Merbecovirus or lineage C (MERS-CoV-); Nobecovirus or lineage D; and Hibecovirus (Decaro and Lorusso, 2020). Among beta-coronaviruses, only beta-coronaviruses lineage A, such as OC43-CoV, encodes HE (Kim, 2020). The HE gene has been transferred to beta-coronavirus lineage A through horizontal gene transmission from an HEF of influenza C (Kim, 2020). In conclusion SARS-CoV-2, like SARS-CoV, lacks the HE gene (Kumar et al., 2020, To et al., 2021, Chan et al., 2020) and it has four structural proteins: spike (S), envelope (E), nucleoprotein (N) and membrane (M) (Troyano-Hernáez et al., 2021); therefore, the seasonal influenza vaccine for 2019/2020 could not have had cross-reactivity with some of the SARS-CoV-2 proteins.
  8 in total

Review 1.  SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.

Authors:  Cheorl-Ho Kim
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

2.  Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.

Authors:  Jasper Fuk-Woo Chan; Kin-Hang Kok; Zheng Zhu; Hin Chu; Kelvin Kai-Wang To; Shuofeng Yuan; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2020-01-28       Impact factor: 7.163

Review 3.  Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses.

Authors:  Nicola Decaro; Alessio Lorusso
Journal:  Vet Microbiol       Date:  2020-04-14       Impact factor: 3.293

4.  Pneumonia in medical professionals during COVID-19 outbreak in cardiovascular hospital.

Authors:  Ivan Ilic; Marina Zdravkovic; Stefan Timcic; Dragana Unic Stojanovic; Milovan Bojic; Goran Loncar
Journal:  Int J Infect Dis       Date:  2020-11-19       Impact factor: 3.623

5.  Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.

Authors:  Paloma Troyano-Hernáez; Roberto Reinosa; África Holguín
Journal:  Viruses       Date:  2021-02-04       Impact factor: 5.048

Review 6.  Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic.

Authors:  Kelvin Kai-Wang To; Siddharth Sridhar; Kelvin Hei-Yeung Chiu; Derek Ling-Lung Hung; Xin Li; Ivan Fan-Ngai Hung; Anthony Raymond Tam; Tom Wai-Hin Chung; Jasper Fuk-Woo Chan; Anna Jian-Xia Zhang; Vincent Chi-Chung Cheng; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

Review 7.  Hemagglutinin-esterase-fusion (HEF) protein of influenza C virus.

Authors:  Mingyang Wang; Michael Veit
Journal:  Protein Cell       Date:  2015-07-28       Impact factor: 14.870

8.  Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings.

Authors:  Ali Pormohammad; Saied Ghorbani; Alireza Khatami; Mohammad Hossein Razizadeh; Ehsan Alborzi; Mohammad Zarei; Juan-Pablo Idrovo; Raymond J Turner
Journal:  Rev Med Virol       Date:  2020-10-09       Impact factor: 11.043

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.